Navigation Links
Key Presentations Announced for Landmark Future of Biosimilars Event Co-Sponsored by DIA and FDLI, Co-Chaired by Merck and PAREXEL
Date:4/28/2011

, will present "FDA: The Agency's Approach to Biosimilars" at 10:00 a.m.
  • Sandra J.P. Dennis, J.D., Deputy General Counsel of the Biotechnology Industry Organization (BIO), and John Coster, Ph.D., RPh, Senior Vice President for Government Affairs, Generic Pharmaceutical Association, will present "Industry Challenges in Developing Biosimilar Medicinal Products" at 11:15 a.m.

  • Susan C. Winckler, President and CEO of FDLI, and Paul Pomerantz, Worldwide Executive Director of DIA, will provide the welcome and opening remarks for the event.  Program Co-Chair Philip L. Huang, MBA, M.D., Vice President, Vaccine Strategy & Innovation, Merck & Co., Inc., will present the first session of the conference entitled "Overview of Biosimilars:  Patient Access, Challenges, Statutory Framework Enacted as Part of Affordable Care Act."

    According to Alberto Grignolo, Ph.D., Corporate Vice President, Global Strategy and Services, PAREXEL Consulting, and a member of the Program Committee, "Participants will learn about all the significant issues, opportunities and challenges associated with biosimilars development and commercialization in the U.S., including the perspective of the FDA. These learnings will provide the foundation for strategic decisions that companies will need to make, and will no doubt lead to further debates, initiatives, and events as this field continues to evolve."

    To access a podcast with a preview of the key issues that will be discussed at the event, including the viewpoints of Program Co-Chair Cecil J. Nick, B.Sc. (Hons), FTOPRA, Vice President, Technical, PAREXEL Consulting, visit:  http://www.fdli.org/podcast/FDLI_Biosimilars_Podcast.mp3.  More in-depth information about the conference can be found in the article

    SOURCE PAREXEL International Corporation
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5

    Related medicine technology :

    1. ULURU Inc. Announces Commercial Exhibit and Scientific Presentations at the SAWC/WHS National Wound Symposium
    2. HeartWare Announces Presentations at The International Society of Heart and Lung Transplantation Annual Meeting
    3. WaferGen Announces Data Presentations From Newly Launched High-Throughput SmartChip Human microRNA Panel V2 at Scientific Conferences, Including AACR
    4. Dendreon Announces Webcast Presentations at Upcoming Conferences
    5. Keryx Biopharmaceuticals Announces Two Poster Presentations on KRX-0401 (Perifosine) at Upcoming American Association for Cancer Research (AACR) Annual Meeting
    6. Idenix Announces Data Presentations at the 46th Annual Meeting of the European Association for the Study of the Liver (EASL)
    7. Thoratec Announces Presentations at Upcoming Investor Conferences
    8. Dehaier Medical Announces March Investor Presentations
    9. Keryx Biopharmaceuticals Announces Upcoming Corporate Presentations
    10. Gen-Probe to Webcast Three Upcoming Investor Presentations
    11. Regeneron Announces March 2011 Investor Conference Presentations
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/7/2015)... July 7, 2015 Noting the need to ... policies currently practiced by the rapidly consolidating pharmacy benefit ... today praised Ohio Governor ... new state effort to help pull back the curtain ... "We applaud Governor Kasich for bringing badly-needed reform ...
    (Date:7/7/2015)... 7, 2015  Dedicated to promoting wellness and giving ... took the purple pledge in support of Alzheimer,s ... Brain-Awareness Month, a time to shine a purple light ... all the people in our community who are affected ... the disease, and helps mobilize friends, family members, neighbors ...
    (Date:7/7/2015)... and BANGALORE , July ... a global technology provider of innovative clinical trial data ... (Industry Standard Research Reports) recent publication named " EDC ... Performance (2015) ". ISR Reports is one of the ... industry, and this report evaluated 22 EDC and eCOA ...
    Breaking Medicine Technology:National LTC Pharmacy Leader Praises Kasich Effort to Bring Transparency to PBM Drug Pricing 2National LTC Pharmacy Leader Praises Kasich Effort to Bring Transparency to PBM Drug Pricing 3Purple for a Purpose: Supporting Alzheimer's & Brain-Awareness Month 2Acceliant Ranked Highest in 'Overall Satisfaction' Amongst EDC Providers in ISR Reports' Recent Research 2Acceliant Ranked Highest in 'Overall Satisfaction' Amongst EDC Providers in ISR Reports' Recent Research 3
    ... D-Pharm announced today the,completion of a financial round, which ... late stage clinical stroke program. The,financial round combined a rights ... of NIS 28 million. The IPO was oversubscribed and the,unit ... minimum price. The,company,s pre-money valuation was NIS 120 million. , ...
    ... , , , ... Drug Administration (FDA) has approved Extavia(R) (interferon beta-1b), the first in a ... patients manage this devastating disease. , , Extavia ... MS to reduce the frequency of clinical exacerbations. The therapy is also ...
    Cached Medicine Technology:D-Pharm Raises NIS 85 Million in Rights Offering and Initial Public Offering (IPO) on the Tel Aviv Stock Exchange (TASE) 2D-Pharm Raises NIS 85 Million in Rights Offering and Initial Public Offering (IPO) on the Tel Aviv Stock Exchange (TASE) 3US FDA Approves Extavia(R) - the First in a New Portfolio of Planned MS Therapies from Novartis to Help Patients with this Devastating Disease 2US FDA Approves Extavia(R) - the First in a New Portfolio of Planned MS Therapies from Novartis to Help Patients with this Devastating Disease 3US FDA Approves Extavia(R) - the First in a New Portfolio of Planned MS Therapies from Novartis to Help Patients with this Devastating Disease 4US FDA Approves Extavia(R) - the First in a New Portfolio of Planned MS Therapies from Novartis to Help Patients with this Devastating Disease 5US FDA Approves Extavia(R) - the First in a New Portfolio of Planned MS Therapies from Novartis to Help Patients with this Devastating Disease 6US FDA Approves Extavia(R) - the First in a New Portfolio of Planned MS Therapies from Novartis to Help Patients with this Devastating Disease 7
    (Date:7/7/2015)... ... July 07, 2015 , ... The Immune Deficiency Foundation ... patient community using its IDF ePHR, an electronic personal health record powered by ... to easily track their health information, including symptoms, diagnoses, medications, infusions and other ...
    (Date:7/7/2015)... ... July 07, 2015 , ... ... Downtown Detroit was the site of the National Baptist Convention 110th Annual Session ... on encouraging and promoting the collaboration of churches and their congregations, medical professionals ...
    (Date:7/7/2015)... (PRWEB) , ... July 07, 2015 , ... Dr. ... on teeth whitening treatments. A professional teeth whitening is one of the fastest, easiest ... as well as they can decrease smile satisfaction and confidence. With the right teeth ...
    (Date:7/7/2015)... ... July 07, 2015 , ... Office Practicum announced today ... Chief Financial Officer, effective July 6th, 2015. Ellen joins Office Practicum with more ... multi-billion dollar, global chemical company to early and growth-stage technology companies. , ...
    (Date:7/7/2015)... Schaumburg, IL (PRWEB) , ... ... ... Solutions, Inc., a leading provider of unified communication management solutions, has announced ... Solution, Infortel® Select. , This service pack includes a number of enhancements ...
    Breaking Medicine News(10 mins):Health News:Get Real Health Launches New Mobile App for Immune Deficiency Foundation Patient Community 2Health News:Get Real Health Launches New Mobile App for Immune Deficiency Foundation Patient Community 3Health News:A Forever Recovery CEO Per Wickstrom Speaks to Audience at National Baptist Convention's 11th Annual Health Fair 2Health News:A Forever Recovery CEO Per Wickstrom Speaks to Audience at National Baptist Convention's 11th Annual Health Fair 3Health News:Los Angeles Cosmetic Dentist, Poneh Ghasri DDS, Now Offers Promotions on Whitening Treatments 2Health News:Los Angeles Cosmetic Dentist, Poneh Ghasri DDS, Now Offers Promotions on Whitening Treatments 3Health News:Office Practicum Announces new CFO 2Health News:ISI Telemanagement Solutions, Inc. Releases Service Pack 5600 for Infortel® Select 2
    ... can benefit from 'keyhole' surgery, according to a new study. ... for a number of operations. It scores because there is ... operation. Non-invasive surgery involves a tiny incision through which miniature ... a guide through the operation. // ,It's ...
    ... gastrointestinal symptoms such as incontinence and nausea, according ... intestinal troubles may be a result of poor ... effect of diabetes medications, researchers suggest. Gastrointestinal symptoms ... constipation have been thought to occur in diabetics ...
    ... Scientists are close to uncovering a gene that may influence ... is helping Cancer Research Campaign scientists learn more of the ... of this family have died of this cancer over five ... skin disorder called tylosis. , // ,The researchers ...
    ... fish, green vegetables, fruit, and milk may reduce the risk ... development of cancer. Eating large amounts of fish could protect ... may only have a moderating effect and smokers should not ... long as they eat fish. // ,Eating large ...
    ... drug that breaks down collagen bonds in the body's ... older people, according to a study conducted by National ... suggests the medication could be a new treatment for ... diabetes. The drug, ALT-711, snips bonds or crosslinks created ...
    ... proteins chemically related to snake venom and frog ... new treatments for a range of stubborn digestive ... two naturally occurring human proteins, which the researchers ... a tale of biological detective work mixing traditional ...
    Cached Medicine News:Health News:Snake venom a treatment for digestive disease 2
    19 gauge x 8 mm with 15 cm high pressure extension tube preattached to a 10C ring control syringe. 3 per box....
    Angled, 20 gauge x 25 mm cannula with 30 gauge x 5 mm tip. 30 gauge cannula extends into hub 2 mm from end of hub, angled 45 degrees 2.5 mm from tip. 10 per box....
    The moist air humidifying chamber is designed for the infusion of humidified air during phakic fluid air exchange. Sterile single-use. 10 per box. Most popular size or model....
    Includes one aluminum Fox eye shield and one eye Garter shield cover. Packaged 50 per box. White only....
    Medicine Products: